As the largest single source of health insurance and coverage for behavioral health services in the country, Medicaid plays a pivotal role in addressing substance use disorder (SUD). Medicaid covers nearly 4 in 10 non-elderly adults in the country with opioid addiction. But this coverage could go further: at least 17 percent of opioid addicts are uninsured, a rate nearly 50 percent higher than the general population.
The U.S. Department of Health and Human Services (HHS) has proposed a new rule that is dangerous to consumers and to health care marketplaces. This rule would expand the sale of “short-term limited duration plans” that do not have to comply with the consumer protections afforded under the Affordable Care Act (ACA) and often leave consumers uncovered for major medical expenses.
Racial discrimination in the United States is pervasive and affects health outcomes and access to health care on multiple levels—from the interpersonal, to the institutional, to deeper structural divides. Such ingrained racism creates significant barriers for people of color, making it harder for them to get equal access to jobs, housing, education, and health care services.
Since the Trump Administration took office, several states have asked the Centers for Medicare and Medicaid Services (CMS) for approval to waive Medicaid requirements or add new ones through requests known as Medicaid Section 1115 waivers. View our timeline below of the different stages that occur before these requests get to CMS.
As of April 2018, 18 states were actively pursuing Medicaid waivers that would kick people off the program or impose punitive requirements. And the list continues to grow. Advocates for affordable, high-quality, and equitable health care can play a vital role in opposing these waivers. Share this toolkit on Twitter.
By weakening the standards around what benefits health plans must cover and other changes, the latest policy from the Trump Administration will threaten the quality and affordability of health coverage.
Under a proposed rule open for comment until April 23, 2018, the Trump administration wants to expand the sale of substandard, sham health insurance. If finalized in its current form, this rule will harm consumers and the insurance market.
The comment period for the public to speak out against the rule has closed. View Families USA's comments.
Today, the Congressional Budget Office (CBO) released a new budget baseline for 2018 to 2028. The baseline report shows a significant increase in projected budget deficits compared to the 2017 baseline.
One Illinois legislator is taking action so that residents in his state will no longer have to suffer without recourse when generic drug manufacturers engage in the practice of price gouging. Families USA has been proud to work with State Representative Will Guzzardi from Illinois’ 39th District on HB 4900, legislation that Rep. Guzzardi introduced in the state legislature to create generic drug pricing fairness and stop price gouging in Illinois.
Here Families USA interviews Rep. Guzzardi on how high prescription drug prices hurt Illinois families, and how HB 4900 will help make drugs more affordable in the state.
Trump Administration 'Public Charge' Rule Threatens Health Care for Immigrant Families, Including U.S. Citizen Children
The impact of a proposed Trump administration rule extends well beyond the directly targeted individuals and families whose health will be at risk. A community’s overall health depends on the health of all of its members. The impact of this proposed rule will spill over to others in many ways. Without insurance, families may delay care or forego it altogether. This means there will be more children in school, and adults in the workplace, without needed preventive services and untreated illnesses. More people delaying care until the last possible moment will strain emergency resources. Hospitals’ and clinics’ uncompensated care burdens will increase.